BIO Submits Comments Re: HRSA's PPA Information Collection Request
<div>
Captain Krista M. Pedley, PharmD, M.S., USPHS, Director</div>
<div>
Office of Pharmacy Affairs</div>
<div>
Health Resources and Services Administration</div>
<div>
Department of Health and Human Services</div>
<div>
5600 Fishers Lane, Parklawn Building, Mail Stop 10C-03</div>
<div>
Rockville, Maryland 20857</div>
<div>
</div>
<div>
BY ELECTRONIC SUBMISSION</div>
<div>
</div>
<div>
Re: Proposed Information Collection: Enrollment and Re-Certification of Entities</div>
<div>
in the 340B Drug Pricing Program and Collection of Manufacturer Data to Verify</div>
<div>
340B Drug Pricing Program Ceiling Price Calculations [OMB No. 0915-0327-</div>
<div>
Revision]</div>
<div>
</div>
<div>
Dear Captain Pedley:</div>
<div>
</div>
<div>
The Biotechnology Industry Organization (“BIO”) appreciates the opportunity to</div>
<div>
submit the following comments in response to the proposed Information Collection Request</div>
<div>
(“ICR”), issued by the Health Resources and Services Administration (“HRSA”) and</div>
<div>
published in the Federal Register on October 20, 2015, entitled Enrollment and Re-</div>
<div>
Certification of Entities in the 340B Drug Pricing Program and Collection of Manufacturer</div>
<div>
Data to Verify 340B Drug Pricing Program Ceiling Price Calculations [OMB No. 0915-0327-</div>
<div>
Revision] (the “Proposed ICR”).</div>
